Skip to main content
Equibles

NBTX · Nanobiotix S.A.

Track NBTX — free

Use NBTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NBTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$25.10 -0.65 (-2.52%)
Rebalance outlook locked
Market Cap
$1.70B
Shares
50.92M
Volume · Oct 5 194.26K Avg daily vol (3M) 148.09K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$25.75 Open$27.39 Day$25.23–27.43 52W close$15.08–55.07 Avg vol 30d154K Short int176K · 0.3% float · 1.4d Short vol42% Last earningsApr 1, 2026 DataDec 2020–Oct 2026

Up next

Q4 2025 earnings call transcript
call held Dec 31, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$13.42M
Trailing 12 months
Net income (TTM)
−$61.67M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-256.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-2.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.1%
Year over year · more shares
Price change (1Y)
+29.5%
Trailing year
Short interest
0.3%
Latest settlement · 1.4 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −23%
below
Price vs 50-day avg −32%
below
RSI (14) 25
oversold
MACD trend Negative
52-week position 27%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −36%
trailing
6-month return −20%
trailing
YTD return +11%
this year
Relative strength −32%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $38 › 200d $33 — 50d above 200d
Institutional flow Accumulating
+27% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.35% of float · ▲ +17.9% MoM · 1.4 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
19 holders — near 3-yr high, broad support
Squeeze score 43
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 103%
annualized · 1-yr
Max drawdown −53%
past year
ATR 9.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−23% Bearish
Price vs 50-day avg
−32% Bearish
RSI (14)
25 Neutral
MACD trend
Negative Bearish
52-week position
27% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $38 › 200d $33 — 50d above 200d
Institutional flow Accumulating
+27% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.35% of float · ▲ +17.9% MoM · 1.4 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
19 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $15 Now $26 · 27% Range high $55
vs 200-day avg -23% vs 50-day avg -32%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NBTX
Nanobiotix S.A.
this stock
$1.70B +11.4% — — 0.3%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +544.3% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
19
% held
11.4%
Net QoQ
+94.4K sh
Top holder
JOHNSON & JOHNSON
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Rising
Shares short
176.0K
Days to cover
1.4d
Change
+26.8K sh
View
Short Volume
Short vol %
42%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
19.5K
Value
$723.1K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
36.2%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 1, 2026
This year
30
View
Earnings & Events
Webcasts
Last webcast
Apr 1, 2026
View

Performance

5D 20D 120D MTD YTD
NBTX -22.7% -35.6% -19.5% -17.4% +11.4%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -22.5% -35.2% -31.7% -18.3% -1.5%
Key facts CIK 1760854 CUSIP 63009J107 Visit website Investor relations